Edward Borkowski - Jan 3, 2022 Form 4 Insider Report for First Wave BioPharma, Inc. (FWBI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FWBI	Stock option (right to buy)	Award	$0	+34.5K		$0.00	34.5K	Jan 3, 2022	Common stock, par value $0.0001 per share	34.5K	$1.45	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option vests in equal quarterly installments on each of March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.